Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-20

Clinical Trial Update: Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the efficacy and safety of a topical amphotericin B solution for resistant tinea capitis in children aged 16 or younger, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Amphotericin B Solution (amphotericin B)

Snippet

Sponsor: Sohag University | Conditions: Tinea Capitis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING